NMVLX | VMVAX | NMVLX / VMVAX | |
Total Expense Ratio | 0.94 | 0.07 | 1,343% |
Annual Report Gross Expense Ratio | 0.99 | 0.07 | 1,414% |
Fund Existence | 12 years | 14 years | - |
Gain YTD | 2.903 | 5.592 | 52% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 3000 | 333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 500M | 31B | 2% |
Annual Yield % from dividends | 2.69 | 2.22 | 121% |
Returns for 1 year | -1.80 | 8.08 | -22% |
Returns for 3 years | -1.97 | 17.95 | -11% |
Returns for 5 years | 4.94 | 65.77 | 8% |
Returns for 10 years | 36.12 | 88.57 | 41% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DWX | 43.01 | 0.10 | +0.24% |
SPDR® S&P® International Dividend ETF | |||
MARM | 32.35 | N/A | N/A |
FT Vest U.S. Eq Max Buffr ETF - Mar | |||
ITDG | 35.76 | -0.01 | -0.04% |
iShares LifePath Target Date 2055 ETF | |||
QDTY | 44.98 | -0.19 | -0.41% |
YieldMax Nasdaq 100 0DTE Cove CllStgyETF | |||
TECL | 105.80 | -2.60 | -2.40% |
Direxion Daily Technology Bull 3X ETF |